Legal Representation
Attorney
Christie Baty Hudgins
USPTO Deadlines
Next Deadline
165 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 30, 2025
Extension Available
Until December 30, 2025
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 20, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 20, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 31, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 2, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jul 2, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Apr 5, 2024 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for gene therapy; pharmaceutical preparations that use genome editing to treat genetic, oncological, and immune system disorders and diseases
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINE"